Back to stocks
SKYE

SKYE

Skye Bioscience, Inc.• Healthcare

Institutional holders
19
As of Q3 2026
Total 13F value
$3.1M
Sum of disclosed positions
New positions
17
This quarter
Sold positions
42
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

5Am Venture Management, Llc

$1.6M981.3K0.53%Exited

Versant Venture Management, Llc

$404K251.0K0.37%Exited

Tang Capital Management Llc

$322K200.0K0.01%New Position

Baker Bros. Advisors Lp

$317K196.9K0.00%Exited

Citadel Advisors

$185K114.9K0.00%New Position

Sphera Funds Management Ltd.

$140K87.3K0.02%-87.2%

Blackrock, Inc.

$47K29.1K0.00%Exited

Vanguard Capital Management Llc

$42K26.0K0.00%Exited

Millennium Management

$24K14.6K0.00%Exited

Vanguard Fiduciary Trust Co

$19K11.5K0.00%Exited

Virtu Financial Llc

$18K11.2K0.00%New Position

Royal Bank Of Canada

$2K1.1K0.00%Exited

Tower Research Capital Llc (Trc)

$2K1.1K0.00%New Position

Vanguard Global Advisers, Llc

$9165690.00%Exited

Morgan Stanley

$3912430.00%Exited

National Bank Of Canada /Fi/

$80500.00%Exited

Federation Des Caisses Desjardins Du Quebec

$850.00%Exited

Rockefeller Capital Management L.P.

$640.00%Exited

Ifp Advisors, Inc

$010.00%Unchanged

Explore